Literature DB >> 30579818

Use of botulinum toxin in Parkinson's disease.

Angeline Jocson1, Mark Lew2.   

Abstract

Botulinum toxin has emerged as an important therapeutic intervention within the realm of movement disorders, especially for focal and generalized dystonias. Botulinum toxin has additionally been used for a variety of symptoms associated with parkinsonism. In this review, we will specifically evaluate use of botulinum toxin in idiopathic Parkinson's disease. We will discuss symptoms including sialorrhea, limb, dystonia, tremor, dyskinesias, freezing of gait, camptocormia, pisa syndrome, urinary dysfunction, constipation, dysphagia, eyelid opening apraxia, and blepharospasm.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Botulinum toxin; Parkinson's disease

Mesh:

Substances:

Year:  2018        PMID: 30579818     DOI: 10.1016/j.parkreldis.2018.12.002

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

1.  Botulinum toxin application to the internal and external oblique muscles for abdominal spasms in spinal cord injury.

Authors:  Osman Albayrak; Özge Keniş Coşkun; Esra Giray; Evrim Karadağ-Saygı
Journal:  Spinal Cord Ser Cases       Date:  2021-08-19

2.  Evidence-Based Recommendations for the Oral Health of Patients with Parkinson's Disease.

Authors:  Ana L C Martimbianco; Fabio C Prosdocimi; Camillo Anauate-Netto; Elaine M Dos Santos; Gustavo D Mendes; Yara D Fragoso
Journal:  Neurol Ther       Date:  2021-03-18

Review 3.  Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal.

Authors:  Wolfgang H Jost
Journal:  Toxins (Basel)       Date:  2021-01-25       Impact factor: 4.546

Review 4.  Botulinum Toxin in Movement Disorders: An Update.

Authors:  Charenya Anandan; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-01-08       Impact factor: 4.546

Review 5.  Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.

Authors:  Steven D Mitchell; Christos Sidiropoulos
Journal:  Toxins (Basel)       Date:  2021-03-19       Impact factor: 4.546

6.  Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.

Authors:  Veronica Antipova; Carsten Holzmann; Alexander Hawlitschka; Martin Witt; Andreas Wree
Journal:  Toxins (Basel)       Date:  2021-07-20       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.